SV

Street Verdict

Analyst Scorecard

A record of what Rajesh Palviya said publicly, with the source. Not advice.

“Bullish on Metropolis Healthcare Ltd, which is in a strong uptrend, forming higher tops and bottoms, and well-placed above its key SMAs. The weekly and monthly RSI are in favorable territory, indicating rising strength. Investors should consider buying, holding, and accumulating, with an expected upside of 2320-2550 and support at 2100-2070 levels.”

Rajesh Palviya’s track record (trackable calls only): 95 graded calls · 95% CI 46–65%

Metropolis Healthcare LtdBullishCalled 29 Aug 2025Graded 03 Aug 2026
Verdict:HIT

How this call is judged

A call is judged on closing prices only: a close at its target is a hit and a close at its stop is a miss. A call that states an entry starts at the first close that reaches it; if none does in the days allowed, it was never triggered, is not graded and counts toward no hit rate.

No entry price is stated, so the call starts at the first close after it was published.

Target ₹2,320, as stated.

Window: 12 months, the default when no time frame is stated.

The target ₹2,320 was reached on a close. Hit.

The grader’s working: R4 TARGET_CALL: entered ₹2148.6 on 2025-09-01 (next trading session's close); target ₹2320 reached at close ₹2342 on 2026-07-28. Window 365 days — rule H3: a target call whose quote states no time frame is given 12 months, the broker convention.

How it played out

How this is worked out
Time to target
The target was reached on a close 222 trading sessions (330 calendar days) after the entry.
Worst close against it
The closing price went as far as 21.48% against the call before the target was reached, measured from the entry price. Closing prices only; an intraday dip is never counted.

From the entry the grade used, on closing prices. This is a record of one past call and is not advice.

Tracking Metropolis Healthcare Ltd since this call

1-year tracking window
Read the original articleSee Rajesh Palviya’s full track record